Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing
NCT ID: NCT04681300
Last Updated: 2021-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2021-02-28
2021-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The mechanisms triggering PN are still unknown. However, recent findings suggest a major role for the Th2 inflammatory pathway.
Beyond advancing the basic understanding of PN pathophysiology, our study might also pave the way for developing novel Th2-targeted therapeutic strategies for PN and AD. The primary objective of this study is to characterize the transcriptional profile of the T lymphocytes isolated from skin samples from patients with PN. This study will allow a gain a deeper understanding of the pathophysiologic mechanism of PN, a better classification of its subtypes, as well as their physiopathologic link with AD. Moreover, it will help shape new effective and safe therapeutic approaches in these diseases which are important for optimal therapeutic management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
NCT02680405
A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
NCT06934980
Skin Tape Transcriptome Methods in Children
NCT04180644
Registry for the Atopic Dermatitis Research Network
NCT01494142
Causes of Chronic Pruritus
NCT04949893
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with atopic Prurigo nodularis , non-atopic Prurigo nodularis or atopic dermatitis
Skin biopsy
a skin sample will be taken using a 4 mm punch biopsy in lesional skin
Patients with plastic surgery interventions
Plastic surgery remnants
healthy skin from plastic surgery interventions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skin biopsy
a skin sample will be taken using a 4 mm punch biopsy in lesional skin
Plastic surgery remnants
healthy skin from plastic surgery interventions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signature of the written contentment
* Clinical diagnostic of PN defined by the following: a minimum of 20 PN lesions, in total on both legs, and/or both arms; an average worst itch score of ≥7. Atopic PN will be defined as PN associating clinical sings or history of AD according to Hanifin et Rajka criteria. Non-Atopic PN will be defined as PN non-associated with clinical sings or history of AD according to Hanifin et Rajka criteria.
* or confirmed diagnosis of AD according to Hanifin et Rajka criteria without associated PN.
* Washout period for topical treatments (\> 1 week) ans systemic treatments (\> 1 month).
* Indication and absence of contraindication to performing a skin biopsy as part of the treatment
* more than 18 years of age
* Signature of the written contentment
* Hospitalised in the plastic surgery department of Saint-Louis Hospital.
* No associated inflammatory or tumoral skin condition
* No contraindication for biopsy
Exclusion Criteria
* Treatment induced pruritus
* Pruritus secondary to other medical conditions such as bullous dermatosis, renal insufficiency, infectious diseases, …)
* AD under biologic therapy
* Patient under guardianship or conservatorship
* No health insurance coverage
* Patient under State Medical Assistance (AME)
* Pregnancy or breastfeeding
* Persons deprived of their liberty by a judicial or administrative decision
* People undergoing psychiatric care making their consent impossible
* Adults who are the subject of a legal protection measure or unable to express their consent
* Patients unable to read and write
* Inflammatory or tumoral medical condition
* Biological therapy for any other medical condition
* Associated inflammatory or tumoral skin condition
* Pregnancy or breastfeeding
* Persons deprived of their liberty by a judicial or administrative decision
* People undergoing psychiatric care making their consent impossible
* Adults who are the subject of a legal protection measure or unable to express their consent
* Patients unable to read and write
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP200325
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.